Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Duché Pharma, officially known as Laboratoire Duché, is a French pharmaceutical company specializing in over-the-counter (OTC) healthcare products, particularly for ear, nose, and throat (ENT) conditions. Founded in 1948 and headquartered near Dijon, the company is best known for its range of throat lozenges and sprays that combine antiseptic and anesthetic properties. In 1998, it was acquired by the Urgo Group, a leading international healthcare company, to bolster its consumer health portfolio. Today, Duché Pharma operates as a key brand within Urgo's respiratory health division, maintaining a strong presence in French pharmacies. The company's products are designed to provide rapid symptomatic relief for minor ailments like sore throats and coughs. Its integration into Urgo has enabled broader distribution and continued product refinement within the European market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Duche Pharma.